Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 54, 2019 - Issue 6
Submit an article Journal homepage
2,547
Views
15
CrossRef citations to date
0
Altmetric
Original Article

Pharmacokinetics of golimumab in moderate to severe ulcerative colitis: the GO-KINETIC study

Sophie E. BerendsDepartment of Gastroenterology and Hepatology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands; ;Hospital Pharmacy, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands; ORCID Iconhttp://orcid.org/0000-0002-3236-0698View further author information
ORCID Icon,
Anne S. StrikDepartment of Gastroenterology and Hepatology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands; ORCID Iconhttp://orcid.org/0000-0001-8879-4359View further author information
ORCID Icon,
Jeroen M. JansenDepartment of Gastroenterology and Hepatology, Onze Lieve Vrouwe Gasthuis, Amsterdam, Netherlands; View further author information
,
Nanne K. de BoerDepartment of Gastroenterology and Hepatology, Amsterdam UMC, Vrije Universiteit Amsterdam, AG&M Research Institute, Amsterdam, NetherlandsView further author information
,
Pleun S. van EgmondHospital Pharmacy, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands; View further author information
,
Johannan F. BrandseDepartment of Gastroenterology and Hepatology, Amsterdam UMC, Vrije Universiteit Amsterdam, AG&M Research Institute, Amsterdam, NetherlandsView further author information
,
Ron A. MathôtHospital Pharmacy, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands; View further author information
,
Geert R. D’HaensDepartment of Gastroenterology and Hepatology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands; View further author information
&
Mark LöwenbergDepartment of Gastroenterology and Hepatology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands; Correspondence[email protected]
View further author information
 show all
Pages 700-706 | Received 26 Feb 2019, Accepted 12 May 2019, Published online: 27 May 2019

Citations (15)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Suzanne I. Anjie, Melanie S. Hulshoff & Geert D’Haens. (2023) Efficacious dosing regimens for anti-TNF therapies in inflammatory bowel disease: where do we stand?. Expert Opinion on Biological Therapy 23:4, pages 341-351.
Read now
Quan Lu, Mei-feng Yang, Yu-jie Liang, Jing Xu, Hao-ming Xu, Yu-qiang Nie, Li-sheng Wang, Jun Yao & De-feng Li. (2022) Immunology of Inflammatory Bowel Disease: Molecular Mechanisms and Therapeutics. Journal of Inflammation Research 15, pages 1825-1844.
Read now
Konstantinos Papamichael & Adam S. Cheifetz. (2021) Optimizing therapeutic drug monitoring in inflammatory bowel disease: a focus on therapeutic monoclonal antibodies. Expert Opinion on Drug Metabolism & Toxicology 17:12, pages 1423-1431.
Read now
Carl Eriksson, Isabella Visuri, Lina Vigren, Linda Nilsson, Anders Kärnell, Henrik Hjortswang, Daniel Bergemalm, Sven Almer, Erik Hertervig, Per Karlén, Hans Strid & Jonas Halfvarson. (2021) Clinical effectiveness of golimumab in ulcerative colitis: a prospective multicentre study based on the Swedish IBD Quality Register, SWIBREG. Scandinavian Journal of Gastroenterology 56:11, pages 1304-1311.
Read now
Anne S Strik, Sophie E Berends & Mark Löwenberg. (2019) Therapeutic drug monitoring-based dosing of TNF inhibitors in inflammatory bowel disease: the way forward?. Expert Review of Clinical Pharmacology 12:9, pages 885-891.
Read now

Articles from other publishers (10)

Lea Catharina Berkhout, Merel Jeanne I'Ami, Simone Kruithof, Erik Hans Vogelzang, Femke Hooijberg, Margaretha Hendrika Louise Hart, Arthur Ebel Herman Bentlage, Debby Thomas, Severine Vermeire, Gestur Vidarsson, Anja ten Brinke, Michael Twahier Nurmohamed, Gerrit Jan Wolbink & Theo Rispens. (2023) Formation and clearance of TNF–TNF inhibitor complexes during TNF inhibitor treatment. British Journal of Pharmacology.
Crossref
Marco Valvano, Annalisa Capannolo, Nicola Cesaro, Gianpiero Stefanelli, Stefano Fabiani, Sara Frassino, Sabrina Monaco, Marco Magistroni, Angelo Viscido & Giovanni Latella. (2023) Nutrition, Nutritional Status, Micronutrients Deficiency, and Disease Course of Inflammatory Bowel Disease. Nutrients 15:17, pages 3824.
Crossref
Mathurin Fumery, Stéphane Nancey, Jérôme Filippi, Romain Altwegg, Xavier Hébuterne, Gilles Boshetti, Mathilde Barraud, Jonathan Meynier, Stéphane Paul & Xavier Roblin. (2023) Effectiveness of golimumab intensification in ulcerative colitis: A multicentric prospective study. Alimentary Pharmacology & Therapeutics 57:11, pages 1290-1298.
Crossref
Jan Marsal, Manuel Barreiro-de Acosta, Irina Blumenstein, Maria Cappello, Thomas Bazin & Shaji Sebastian. (2022) Management of Non-response and Loss of Response to Anti-tumor Necrosis Factor Therapy in Inflammatory Bowel Disease. Frontiers in Medicine 9.
Crossref
Peter M. Irving & Krisztina B. Gecse. (2022) Optimizing Therapies Using Therapeutic Drug Monitoring: Current Strategies and Future Perspectives. Gastroenterology 162:5, pages 1512-1524.
Crossref
Geert R D'Haens & Sander van Deventer. (2021) 25 years of anti-TNF treatment for inflammatory bowel disease: lessons from the past and a look to the future. Gut 70:7, pages 1396-1405.
Crossref
Antonello Di Paolo & Giacomo Luci. (2021) Personalized Medicine of Monoclonal Antibodies in Inflammatory Bowel Disease: Pharmacogenetics, Therapeutic Drug Monitoring, and Beyond. Frontiers in Pharmacology 11.
Crossref
Sebastian Stefanovic, Iris Detrez, Griet Compernolle, Els Brouwers, Nejc Sever, Borut Stabuc, Natasa Smrekar, Tina Kurent, Gregor Novak, Matic Kozelj, Marc Ferrante, Ann Gils & David Drobne. (2020) Endoscopic remission can be predicted by golimumab concentrations in patients with ulcerative colitis treated with the changed label. European Journal of Gastroenterology & Hepatology 33:1, pages 54-61.
Crossref
Marjorie Argollo, Paulo Gustavo Kotze, Pradeep Kakkadasam & Geert D’Haens. (2020) Optimizing biologic therapy in IBD: how essential is therapeutic drug monitoring?. Nature Reviews Gastroenterology & Hepatology 17:11, pages 702-710.
Crossref
Sarah E. Shannahan, Konstantinos Papamichael & Adam S. Cheifetz. (2020) Evidence Supporting High-Dose Use of Biologics in Clinical Practice. Current Treatment Options in Gastroenterology 18:3, pages 408-422.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.